CME [CME] vs S&P Global [SPGI] Detailed Stock Comparison
CME
NASDAQ
Loading...
S&P Global
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CME wins in 13 metrics, S&P Global wins in 7 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CME | S&P Global | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.17 | 36.64 | CME |
| Price-to-Book Ratio | 3.45 | 4.36 | CME |
| Debt-to-Equity Ratio | 13.60 | 31.65 | CME |
| PEG Ratio | 1.67 | 4.38 | CME |
| EV/EBITDA | 21.44 | 22.07 | CME |
| Profit Margin (TTM) | 58.59% | 27.29% | CME |
| Operating Margin (TTM) | 66.87% | 42.69% | CME |
| EBITDA Margin (TTM) | 66.87% | 42.69% | CME |
| Return on Equity | 13.61% | 11.29% | CME |
| Return on Assets (TTM) | 1.74% | 6.26% | S&P Global |
| Free Cash Flow (TTM) | $3.60B | $5.57B | S&P Global |
| Dividend Yield | 4.30% | 0.55% | CME |
| 1-Year Return | 17.93% | -6.32% | CME |
| Price-to-Sales Ratio (TTM) | 15.14 | 9.90 | S&P Global |
| Enterprise Value | $97.48B | $160.25B | S&P Global |
| EV/Revenue Ratio | 15.15 | 10.90 | S&P Global |
| Gross Profit Margin (TTM) | 86.90% | 70.20% | CME |
| Revenue per Share (TTM) | $18 | $48 | S&P Global |
| Earnings per Share (Diluted) | $10.16 | $13.01 | S&P Global |
| Beta (Stock Volatility) | 0.43 | 1.19 | CME |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
CME vs S&P Global Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CME | -0.29% | -2.08% | -1.74% | -4.35% | -1.38% | 13.73% |
| S&P Global | 0.67% | -1.51% | -11.02% | -9.40% | -1.96% | -3.17% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CME | 17.93% | 55.76% | 56.23% | 199.74% | 404.33% | 294.38% |
| S&P Global | -6.32% | 57.56% | 34.49% | 434.67% | 1,297.64% | 920.00% |
News Based Sentiment: CME vs S&P Global
CME
News based Sentiment: POSITIVE
CME Group is demonstrating strong financial performance and strategic growth, particularly in the rapidly expanding cryptocurrency market. The upcoming earnings report and new product launches represent key catalysts for continued positive momentum, despite some mixed signals from institutional investors.
S&P Global
News based Sentiment: POSITIVE
October saw S&P Global receive positive analyst attention, expand its business through acquisition, and launch a new ESG platform, while also navigating a projected revenue decrease and experiencing mixed credit rating activity across different entities. The overall narrative suggests a company focused on strategic growth and profitability despite some headwinds.
Performance & Financial Health Analysis: CME vs S&P Global
| Metric | CME | SPGI |
|---|---|---|
| Market Information | ||
| Market Cap | $96.97B | $149.43B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,918,300 | 2,139,140 |
| 90 Day Avg. Volume | 1,895,850 | 1,457,923 |
| Last Close | $264.67 | $479.81 |
| 52 Week Range | $213.94 - $290.79 | $427.14 - $579.05 |
| % from 52W High | -8.98% | -17.14% |
| All-Time High | $290.79 (Jun 02, 2025) | $579.05 (Aug 14, 2025) |
| % from All-Time High | -8.98% | -17.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.06% |
| Quarterly Earnings Growth | 0.16% | 0.06% |
| Financial Health | ||
| Profit Margin (TTM) | 0.59% | 0.27% |
| Operating Margin (TTM) | 0.67% | 0.43% |
| Return on Equity (TTM) | 0.14% | 0.11% |
| Debt to Equity (MRQ) | 13.60 | 31.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $77.13 | $109.37 |
| Cash per Share (MRQ) | $5.82 | $6.05 |
| Operating Cash Flow (TTM) | $4.20B | $5.58B |
| Levered Free Cash Flow (TTM) | $2.92B | $4.93B |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.30% | 0.55% |
| Last 12-Month Dividend | $11.85 | $2.78 |
Valuation & Enterprise Metrics Analysis: CME vs S&P Global
| Metric | CME | SPGI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.17 | 36.64 |
| Forward P/E | 25.64 | 28.35 |
| PEG Ratio | 1.67 | 4.38 |
| Price to Sales (TTM) | 15.14 | 9.90 |
| Price to Book (MRQ) | 3.45 | 4.36 |
| Market Capitalization | ||
| Market Capitalization | $96.97B | $149.43B |
| Enterprise Value | $97.48B | $160.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 15.15 | 10.90 |
| Enterprise to EBITDA | 21.44 | 22.07 |
| Risk & Other Metrics | ||
| Beta | 0.43 | 1.19 |
| Book Value per Share (MRQ) | $77.13 | $109.37 |
Financial Statements Comparison: CME vs S&P Global
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CME | SPGI |
|---|---|---|
| Revenue/Sales | $1.64B | $3.78B |
| Cost of Goods Sold | $206.70M | $1.15B |
| Gross Profit | $1.44B | $2.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.11B | $1.57B |
| EBITDA | $476.30M | $1.88B |
| Pre-Tax Income | $1.24B | $1.50B |
| Income Tax | $288.60M | $325.00M |
| Net Income (Profit) | $956.20M | $1.17B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CME | SPGI |
|---|---|---|
| Cash & Equivalents | $1.41B | $1.47B |
| Total Current Assets | $123.45B | $5.34B |
| Total Current Liabilities | $121.42B | $5.92B |
| Long-Term Debt | $3.42B | $11.91B |
| Total Shareholders Equity | $27.03B | $37.73B |
| Retained Earnings | $4.69B | $21.80B |
| Property, Plant & Equipment | $371.20M | $1.50B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CME | SPGI |
|---|---|---|
| Operating Cash Flow | $838.30M | $708.00M |
| Capital Expenditures | $-14.20M | N/A |
| Free Cash Flow | $1.10B | $910.00M |
| Debt Repayment | $-750.00M | $-4.00M |
| Common Stock Repurchase | N/A | $-650.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CME | SPGI |
|---|---|---|
| Shares Short | 4.63M | 3.34M |
| Short Ratio | 2.42 | 3.21 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 1,918,300 | 2,139,140 |
| Average Daily Volume (90 Day) | 1,895,850 | 1,457,923 |
| Shares Outstanding | 359.61M | 307.80M |
| Float Shares | 358.74M | 304.63M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.92% | 0.90% |
Dividend Analysis & Yield Comparison: CME vs S&P Global
| Metric | CME | SPGI |
|---|---|---|
| Last 12-Month Dividend | $11.85 | $2.78 |
| Last 12-Month Dividend Yield | 4.30% | 0.55% |
| 3-Year Avg Annual Dividend | $10.10 | $3.00 |
| 3-Year Avg Dividend Yield | 0.91% | 0.21% |
| 3-Year Total Dividends | $30.30 | $9.00 |
| Ex-Dividend Date | Sep 09, 2025 | Feb 26, 2025 |